Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1659
https://www.valueinhealthjournal.com/article/S1098-3015(14)03589-X/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1136
First Page :
A526
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03589-X&doi=10.1016/j.jval.2014.08.1659